what is wrong with ckpt

It got FDA approval and stock reacted -7%.

In wednesday they manage to up 17% but ended up by -3%

yeah, as you guys said it might dealt with heavy short sellers but what's the point of that when they

got a fcking FDA approval, management will ready for commercialization and might looking for partnership or just dilution but even though they will manage to make revenue around potential 1billion a year I do really not find any valid reason to stock is falling.